Predictors of long‐term visual outcome after chemoreduction for management of intraocular retinoblastoma
- 21 March 2012
- journal article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 40 (7) , 736-742
Abstract
Background: To determine the predictors of long‐term visual outcome after chemoreduction for management of intraocular retinoblastoma.Design: Retrospective case series.Participants: One hundred and forty eyes of 96 new retinoblastoma patients.Methods: The clinical records were reviewed for demographical profile, tumour characteristics, treatment methods, treatment side effects and final visual outcome. Multivariate analysis was used to evaluate factors predictive of final visual acuity.Main Outcome Measure: The clinical data were analysed for main outcome measures of good vision (visual acuity ≥6/12) or ambulatory vision (visual acuity ≥6/60). The correlation among predictor variables was determined using Pearson's product moment correlation for continuous variables, and t‐test and analysis of variance test for categorical baseline variables.Results: Follow‐up ranged from 2 years to 14 years (median 75 months). The final mean logarithm of minimum angle of resolution visual acuity was 0.79. Ambulatory vision (≥6/60) was achieved in 100 of 140 (71%) eyes, and vision of ≥6/12 was seen in 52 eyes (37%). Extrafoveolar tumour and greater number of tumours in the eye were the only predictors of visual acuity ≥20/40. Greater number of tumours correlated with smaller mean basal tumour diameter. The mean basal tumour diameter was 9.8 mm in eyes with multiple tumours and 12.2 mm in eyes with single tumours (P = 0.03).Conclusion: Long‐term ambulatory vision (≥6/60) was achieved in the majority (71%) of retinoblastoma containing eyes not requiring enucleation after treatment with chemoreduction and adjunctive therapy. Absence of foveolar involvement and greater number of tumours were the predictor of long‐ term visual outcome of 6/12 or better.Keywords
This publication has 26 references indexed in Scilit:
- Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapyCurrent Opinion in Ophthalmology, 2010
- Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservationBritish Journal of Ophthalmology, 2009
- Secondary Acute Myelogenous Leukemia in Patients with RetinoblastomaOphthalmology, 2007
- A retrospective review of hearing in children with retinoblastoma treated with carboplatin‐based chemotherapyPediatric Blood & Cancer, 2007
- Current Management Strategies for Intraocular RetinoblastomaDrugs, 2007
- Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumorsAmerican Journal of Ophthalmology, 2004
- Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleationAmerican Journal of Ophthalmology, 2002
- Visual results in children treated for macular retinoblastomaEye, 2002
- Mortality From Second Tumors Among Long-Term Survivors of RetinoblastomaJNCI: Journal of the National Cancer Institute, 1993
- Bilateral retinoblastoma: the prognosis for vision.British Journal of Ophthalmology, 1983